We invite you to attend our seminar on translational pathways for cell and gene therapy, organised by Cambridge Enterprise and the Office of Translational Research (OTR) in collaboration with the Cell and Gene Therapy (CGT) Catapult.
Where: Jeffrey Cheah Biomedical Centre Lecture Theatre, Puddicombe Way Cambridge CB2 0AW
When: Tue, 21 Nov 2023 09:15 – 16:00 GMT
This seminar will provide key insights on:
– Intellectual Property (IP) considerations
– The expertise and resources that the CGT Catapult can provide to help you develop a clinically and commercially viable cell or gene therapy
– The key challenges and non-clinical, regulatory and health economics considerations from across the cell and gene therapy lifecycle for translating your research
– The development path taken by a pioneering cell therapy developed at the University of Cambridge.
University of Cambridge researchers and clinicians working on cell or gene therapies, or technologies that facilitate their development, are invited to attend this free event. You will have the opportunity to meet experts in cell and gene therapy development, share ideas, and learn more about the available support to rapidly progress your research towards patient benefit.
9:15-9:30 – Introduction to cell and gene therapies and the CGT Catapult – Cambridge Enterprise and CGT Catapult
9:30-10:00 – Navigating the regulatory pathway to first-in-human clinical trials (and beyond) – Moira Francois, Regulatory Affairs Manager, CGT Catapult
10:00-10:30 – Non-clinical considerations for stem cell therapeutics – Parto Toofan, Non-clinical Manager, CGT Catapult
10:30-11:00 – How can health economics help development and why you should consider reimbursement earlier rather later – Laura Beswick, Head of Health Economics and Market Access, CGT Catapult
11:00-11:30 – Tea break/networking
11:30-12:00 – Making platelets in vitro: challenges and opportunities – Cedric Ghevaert, University of Cambridge
12:00-12:30 – Cell or Gene Therapy process and product development: Where to begin? – Matt Smart, Lead Scientist in Technology and Process Innovation, CGT Catapult
12:30-13:00 – Next steps and support for translational research – Cambridge Enterprise and the Office for Translational Research
13:00-14:00 – Lunch
14:00-16:00 – Pre-arranged 1-2-1 meetings with CGT Catapult, Cambridge Enterprise and/or the Office for Translation Research
If you are a University of Cambridge academic or clinician working in cell or gene therapy research and on the translational pathway and would like to register for a 1-2-1 meeting with a representative from the CGT Catapult, Cambridge Enterprise and/or the OTR, please indicate this in your ticket registration form. Meetings will occur from 14:00-16:00 on the day of the event.
– Cambridge Enterprise can advise on any queries related to IP, third party funding rights, patent filing, legal agreements (including NDAs), technology licencing and spinouts.
– The Office of Translational Research at the University of Cambridge can advise on funding opportunities and tailoring applications for the right funding.
– CGT Catapult can provide support at every step of your journey to develop your cell or gene therapy, including non-clinical safety considerations, manufacturing process development, regulations, and health economics.
1-2-1 meetings will be subject to availability, and attendees that secure a meeting slot will be notified of the timing, location and the team they will be meeting with (CGT Catapult, Cambridge Enterprise and/or the OTR) in advance of the event. Meeting slots are limited to 20 minutes to ensure there is enough time to speak to all registered attendees.
Posted on 02/11/2023
